Evidence map›Paper›PMID 29577069›Full record

ArticleBiophysics reports2018

Identification of natural products as novel ligands for the human 5-HT

Yao Peng, Simeng Zhao, Yiran Wu, Haijie Cao, Yueming Xu, Xiaoyan Liu, Wenqing Shui, Jianjun Cheng, Suwen Zhao, Ling Shen and 5 more

Abstract read
In one paragraph

Article in Biophysics reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Molecules (Basel, Switzerland) · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yao Peng1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101 China.
Simeng Zhao3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Yiran Wu3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Haijie Cao6College of Pharmacy, Nankai University, Tianjin, 300071 China.
Yueming Xu3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Xiaoyan Liu3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Wenqing Shui3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Jianjun Cheng3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Suwen Zhao3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Ling Shen3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Jun Ma8Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Ronald J Quinn8Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111 Australia.
Raymond C Stevens3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Guisheng Zhong3iHuman Institute, ShanghaiTech University, Shanghai, 201210 China.
Zhi-Jie Liu1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) constitute the largest human protein family with over 800 members, which are implicated in many important medical conditions. Serotonin receptors belong to the aminergic GPCR subfamily and play important roles in physiological and psychological activities. Structural biology studies have revealed the structures of many GPCRs in atomic details and provide the basis for the identification and investigation of the potential ligands, which interact with and modulate the receptors. Here, an integrative approach combining a focused target-specific natural compound library, a thermal-shift-based screening method, affinity mass spectrometry, molecular docking, and

Indexed as

5-HT2C receptorAlkaloidsGPCRNatural product

Identifiers

PMID29577069
PMCPMC5860131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.